Showing results (21-30 of 547) with videos related to
Sort By:
Pageof 55
Chemical Communications (Cambridge, England)|November 1, 2003
H+, Na+ and K+ modulated lanthanide luminescent switching of Tb(III) based cyclen aromatic diaza-crown ether conjugates in waterThorfinnur Gunnlaugsson, Joseph P LeonardChemical Communications (Cambridge, England)|June 22, 2005
Responsive lanthanide luminescent cyclen complexes: from switching/sensing to supramolecular architecturesThorfinnur Gunnlaugsson, Joseph P LeonardHematology. American Society of Hematology. Education Program|December 10, 2013
Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOPLeandro Cerchietti, John P LeonardThe Journal of Urology|March 7, 2006
Watchful waiting for prenatally detected ureterocelesTania Direnna, Michael P LeonardJournal of Neurochemistry|April 12, 2001
Identification of mouse NMDA receptor subunit NR2A C-terminal tyrosine sites phosphorylated by coexpression with v-SrcM Yang, J P LeonardClinical Lymphoma & Myeloma|October 13, 2007
Targeted therapies for non-Hodgkin lymphoma: rationally designed combinationsPeter Martin, John P LeonardBiologics : Targets & Therapy|August 27, 2009
Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin's lymphomaBiree Andemariam, John P LeonardDalton Transactions (Cambridge, England : 2003)|September 21, 2005
Lanthanide luminescent switches: modulation of the luminescence of bis-macrocyclic based Tb(III) conjugates in water by H+, Na+ and K+Thorfinnur Gunnlaugsson, Joseph P LeonardBrain Research|March 28, 1997
Effects of external calcium on zinc modulation of AMPA receptorsJ C Dreixler, J P LeonardSeminars in Oncology|February 14, 2002
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)John P Leonard, Brian K LinkPageof 55